Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries.
about
Integrated analysis of dysregulated ncRNA and mRNA expression profiles in humans exposed to carbon nanotubesEngineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkersCardiovascular effects of pulmonary exposure to single-wall carbon nanotubesNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesNanoparticles - known and unknown health risksThe influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lungTranslocation of particles deposited in the respiratory system: a systematic review and statistical analysisToxicity of nanomaterialsRecent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studiesNanomaterial interactions with and trafficking across the lung alveolar epithelial barrier: implications for health effects of air-pollution particlesCellular and molecular mechanisms in environmental and occupational inhalation toxicologyDetoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatinTranslocation of inhaled ultrafine manganese oxide particles to the central nervous systemNanomedicine in pulmonary deliveryEnvironmentally persistent free radicals inhibit cytochrome P450 activity in rat liver microsomes.Update in environmental and occupational medicine 2006.Health effects of inhaled engineered and incidental nanoparticles.Nonviral vectors for the delivery of small interfering RNAs to the CNS.Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.Health impact and toxicological effects of nanomaterials in the lung.Endocytosis of environmental and engineered micro- and nanosized particles.Foamy macrophage responses in the rat lung following exposure to inhaled pharmaceuticals: a simple, pragmatic approach for inhaled drug development.Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro.Vanadium pentoxide induces activation and death of endothelial cells.Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing.Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein DParticulate matter promotes in vitro receptor-recognizable low-density lipoprotein oxidation and dysfunction of lipid receptors.Sedentary behavior and altered metabolic activity by AgNPs ingestion in Drosophila melanogaster.Microplastics as an emerging threat to terrestrial ecosystems.Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time.Biokinetics of Nanomaterials: the Role of Biopersistence.Polystyrene Nanoparticles Activate Erythrocyte Aggregation and Adhesion to Endothelial Cells.An occupational exposure assessment for engineered nanoparticles used in semiconductor fabrication.
P2860
Q23909992-B36289B7-E24C-4FCF-871D-D5D1EE79EB41Q23919501-804209FC-6D1C-4607-925E-7D95598C6B0EQ23924188-0B358A21-EFD2-4FCD-BBCE-EF2E5703CBA1Q24536032-C2AA4500-5807-4A0C-93F5-83648557C0A1Q24557518-ECB5C14F-A18E-4698-A8A3-D31A2D929322Q24814544-DC2C21C0-1714-4DB5-A9BE-01EC821DA178Q26866541-734EA2F2-E8DB-4B5B-9679-05197248EB5DQ28383168-D9500388-EF72-42CE-BE4D-50FEC0700FEBQ28385376-EF61B123-4404-4702-8DFB-559D06C9F337Q28385393-E0D4C912-B95A-43ED-B3FF-028393D325FBQ28392962-4236E090-1714-42EB-9A2D-90D039BC96BAQ28484446-DE84B1A3-167C-40A1-9899-4E49994ABFDBQ29615577-E380CF5F-48DE-45ED-BC23-F832D1675F27Q33572981-2F941D9B-BA3D-4EEA-8142-CAFC3902264BQ33726949-28C9F150-CE97-48DD-9A3E-F8FDDDC05EEEQ36779230-08B966D7-AE6E-4728-8943-DAD0B5AD82AFQ37594800-987595D4-497B-4314-9A1C-7A40CDAC994FQ37805489-1E5489D3-AD88-44A6-907A-377FF5BF3DC6Q37869062-DE5E32F7-D98D-4B7D-ABFE-90D65112B38EQ37997098-D32CC39B-72B8-400B-A981-1BFF2503957DQ38111706-1A22740A-C01F-494F-8CC0-B9660CFABCB3Q38182903-38C60F1F-0768-44F5-A9E0-FE57698669FDQ39128530-2970EC1B-4DB1-438A-872C-FCFD3C9197B2Q39514689-3D6D8AEB-9F80-4B56-8EBF-02ED0485A863Q39533187-2EA2D672-D8B5-40EE-B18C-858A0541EAD0Q39689683-0C88DD10-7BB6-48A9-A5A4-2D39ED375414Q43168583-4D10724D-BCB4-4C6B-BA90-E9509DD88397Q44404944-57E43239-C0A2-47FB-A7B9-2CF5FF51A117Q46240284-EBE2E540-AE3F-4C79-8979-68CA2535F87BQ47417577-0A78542D-FB79-4A9D-BF74-A56D6869F875Q47745983-E0B8235C-FC98-45BE-9654-AFA815E14BE9Q50249002-EE068A10-99D2-46C4-A3A3-FADF05FDD9ABQ53663895-167F717F-20C5-43E1-AFB8-0F3EB7CBFF25
P2860
Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evidence that exogenous substa ...... ported into blood capillaries.
@ast
Evidence that exogenous substa ...... ported into blood capillaries.
@en
type
label
Evidence that exogenous substa ...... ported into blood capillaries.
@ast
Evidence that exogenous substa ...... ported into blood capillaries.
@en
prefLabel
Evidence that exogenous substa ...... ported into blood capillaries.
@ast
Evidence that exogenous substa ...... ported into blood capillaries.
@en
P2093
P1476
Evidence that exogenous substa ...... ported into blood capillaries.
@en
P2093
Damon C Herbert
Katsuhisa Oshikawa
Masashi Bando
Shoji Ohno
Takashi Yashiro
Tomoko Kato
Yoshio Murata
Yukihiko Sugiyama
P2888
P356
10.1007/S00441-002-0647-3
P577
2002-11-22T00:00:00Z
P6179
1012004145